« BackUrologic Oncology: Seminars and Original Investigations
Article in Press

Tumor cytoreduction results in better response to androgen ablation—a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancer

  • Xiao-Jian Qin, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Chun-Guang Ma, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Ding-Wei Ye, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
    • Corresponding Author InformationCorresponding author. Tel.: +862164175590; fax: +862164175590
  • ,
  • Xu-Dong Yao, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Shi-Lin Zhang, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Bo Dai, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Hai-Liang Zhang, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Yi-Jun Shen, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Yao Zhu, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Yi-Ping Zhu, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Guo-Hai Shi, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Wen-Jun Xiao, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Guo-Wen Lin, M.D.

      Affiliations

    • Department of Urology, Fudan University Shanghai Cancer Centre, Shanghai, China
    • Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China
  • ,
  • Gregory P. Swanson, M.D.

      Affiliations

    • Department of Radiology and Urology, University of Texas Health Science Center, San Antonio, TX 78229, USA

Received 2 November 2009; received in revised form 6 February 2010; accepted 10 February 2010. published online 10 May 2010.
Corrected Proof

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(10)00051-7

doi:10.1016/j.urolonc.2010.02.010

« BackUrologic Oncology: Seminars and Original Investigations